Becton Dickinson & Co
BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3018% above fair value
$216.08+0.66 (+0.31%)
Close on Nov 18, 2026Market cap $58.86BP/E 65.3Yield 1.93%
Becton Dickinson Net Leverage Ratio by Quarter
Net Leverage Ratio (Net Debt / LTM Adjusted EBITDA, x) (×)
Becton Dickinson Net Leverage Ratio: 2.70× in Q4 FY26.
Latest, Q4 FY26
2.70
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
–
History
5 quarters
Since Q4 FY23
Sources
5
Documents cited below
Where the Q4 FY26 figure comes from
“Net Leverage(4) 2.7x”
Source: BD Q4 FY2026 Earnings Presentation ↗
Reported in BD Quarterly Earnings Presentations — Net Leverage Reconciliation.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Leverage Ratio (Net Debt / LTM Adjusted EBITDA, x) (×) | Year on year | Source |
|---|---|---|---|---|
| Q4 FY26CQ3 2026 | Sep 30, 2026 | 2.70 | – | BD Q4 FY2026 Earnings Presentation ↗ |
| Q3 FY26CQ2 2026 | Jun 30, 2026 | 2.90 | – | BD Q3 FY2026 Earnings Presentation ↗ |
| Q2 FY26CQ1 2026 | Mar 31, 2026 | 2.90 | – | BD Q2 FY2026 Earnings Presentation ↗ |
| Q1 FY24CQ4 2023 | Dec 31, 2023 | 2.70 | – | BD Q1 FY2024 Earnings Presentation ↗ |
| Q4 FY23CQ3 2023 | Sep 30, 2023 | 2.60 | – | BD Q4 FY2023 Earnings Presentation ↗ |
Cite this data
StockData. (2026). Becton Dickinson Net Leverage Ratio (×), quarterly Q4 FY23–Q4 FY26 [Data set]. Compiled from Becton Dickinson SEC filings and investor materials. https://stockdatahq.com/stocks/bdx/kpis/lev-ratio
See every metric in the Becton Dickinson KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?